Teladoc Health, Inc. (TDOC)
NYSE: TDOC · IEX Real-Time Price · USD
12.30
-0.43 (-3.38%)
May 20, 2024, 4:00 PM EDT - Market closed
Teladoc Health Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Teladoc Health stock have an average target of 19.74, with a low estimate of 13.5 and a high estimate of 28. The average target predicts an increase of 60.49% from the current stock price of 12.30.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Teladoc Health stock from 18 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 9 | 9 | 9 | 8 | 11 | 12 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 15 | 14 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $17 → $14 | Hold | Maintains | $17 → $14 | +9.76% | May 14, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $17 → $15 | Hold | Maintains | $17 → $15 | +21.95% | Apr 29, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $26 → $21 | Buy | Maintains | $26 → $21 | +70.73% | Apr 26, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +21.95% | Apr 26, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $25 → $18 | Buy | Maintains | $25 → $18 | +46.34% | Apr 26, 2024 |
Financial Forecast
Revenue This Year
2.72B
from 2.60B
Increased by 4.52%
Revenue Next Year
2.82B
from 2.72B
Increased by 3.64%
EPS This Year
-1.05
from -1.34
EPS Next Year
-0.72
from -1.05
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.8B | 3.0B | 3.1B | 3.3B | 3.5B |
| Avg | 2.7B | 2.8B | 2.9B | 3.1B | 3.2B |
| Low | 2.6B | 2.7B | 2.7B | 2.9B | 3.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.3% | 9.3% | 9.0% | 11.7% | 13.0% |
| Avg | 4.5% | 3.6% | 3.5% | 4.7% | 6.0% |
| Low | -0.7% | -1.9% | -2.9% | -1.9% | -1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.77 | -0.17 | 0.66 | -0.41 | 0.07 |
| Avg | -1.05 | -0.72 | -0.38 | -0.40 | 0.07 |
| Low | -1.35 | -1.15 | -0.90 | -0.38 | 0.07 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.